Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation

Mise à jour : Il y a 4 ans
Référence : NCT00983736

Extrait

The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the "study drug"). The patient and the patient's partner are being asked to be in this clinical trial because they have a condition called Premature Ejaculation.


Critère d'inclusion

  • premature ejaculation


Liens